|
시장보고서
상품코드
2091909
리드리스 페이스메이커 시장 규모, 점유율 및 성장 분석 : 제품 유형별, 기술 플랫폼별, 최종사용자별, 유통 채널별, 지역별 - 업계 예측(2026-2033년)Leadless Pacemakers Market Size, Share, and Growth Analysis, By Product Type, By Technology Platform, By End-User, By Distribution Channel, By Region - Industry Forecast 2026-2033 |
||||||
세계의 리드리스 페이스메이커 시장 규모는 2024년에 6억 7,000만 달러로 평가되며, 2025년 7억 7,452만 달러에서 2033년까지 24억 6,999만 달러로 확대하며, 예측 기간(2026-2033년)에 CAGR 15.6%로 성장할 것으로 전망되고 있습니다.
리드리스 심박조율기 시장은 심장 리듬 관리 분야의 혁신을 상징하며, 경정맥 리드를 제거함으로써 감염 위험 감소 및 시술 간소화라는 중요한 이점을 제공합니다. 특히 정맥 접근이 어려운 환자나 리드와 관련된 문제가 지속되고 있는 환자를 대상으로 의료진이 기존 시스템을 대체할 대안을 모색함에 따라 이 시장은 성장세를 보이고 있습니다. 임상의들은 그 유효성과 입원 기간 단축을 이유로 리드리스 기술의 도입을 점점 더 확대하고 있으며, 치료 용도와 보험 급여 범위를 넓히는 중요한 진전이 나타나고 있습니다. 세계적인 고령화와 부정맥 질환의 증가에 따라 최소 침습 치료에 대한 수요가 높아지고 있으며, 병원들은 효율적인 치료 시스템 도입에 투자하고 있습니다. 또한 AI를 활용한 분석을 통해 환자 관리의 개선과 맞춤형 치료가 가능해졌으며, 리드리스 심박조율기의 보급이 촉진되면서 이 혁신적인 기술의 성장을 지원할 유리한 환경이 조성되고 있습니다.
전 세계 리드리스 심박조율기 시장의 성장 요인
전 세계 리드리스 심박조율기 시장의 주요 성장 동인 중 하나는 심혈관 질환 유병률의 증가로, 이로 인해 첨단 심장 치료 솔루션에 대한 수요가 높아지고 있습니다. 환자들이 비침습적인 치료법을 원하는 가운데, 기존의 리드가 필요 없으며 감염증이나 리드 관련 문제와 같은 합병증 위험을 대폭 줄여주는 리드리스 심박조율기는 의료진과 환자 모두로부터 지지를 얻고 있습니다. 또한 의료 기술의 발전과 지속적인 연구개발 노력에 힘입어 리드리스 심박조율기 설계 분야의 혁신이 촉진되고, 그 유효성과 안전성이 향상됨에 따라 임상 현장에서의 도입이 더욱 확대되고 있습니다.
세계 리드리스 심박조율기 시장의 제약 요인
전 세계 리드리스 심박조율기 시장의 주요 제약 요인 중 하나는 기존 심박조율기 시스템에 비해 이러한 첨단 기기의 비용이 높다는 점입니다. 도입에 필요한 초기 투자 비용과 이에 수반되는 치료 비용은, 특히 예산이 제한적인 개발도상 지역의 많은 의료 기관에게 장벽이 될 수 있습니다. 또한 의료 종사자나 환자들 사이에서 리드리스 기술에 대한 인지도와 이해도가 부족한 점도 도입을 저해하는 요인이 될 수 있습니다. 혁신적인 심장용 의료기기에 대한 보험 지급 방침이나 보험 적용 범위 제한과 같은 과제는 시장 침투를 더욱 복잡하게 만들고, 각 지역의 환자 접근성과 시장 전체의 성장 모두에 영향을 미치고 있습니다.
세계 리드리스 심박조율기 시장의 동향
전 세계 리드리스 심박조율기 시장에서는 원격 모니터링 시스템 통합을 향한 큰 변화가 나타나고 있습니다. 이러한 동향은 지속적인 원격 모니터링을 중시하며, 의료진이 기기의 성능과 환자의 생체 리듬 데이터를 원활하게 추적할 수 있도록 합니다. 대면 진료 횟수를 줄임으로써, 이러한 혁신적인 기술들은 부정맥 증상의 조기 발견을 촉진하고, 선제적인 임상적 의사결정을 지원합니다. 전 세계 원격의료 인프라의 확충이 이러한 수요를 더욱 부추기고 있으며, 임상의들은 통합된 플랫폼으로의 효율적인 데이터 전송을 보장함으로써 환자의 안전성과 편의성을 향상시키는 솔루션을 선호하고 있습니다. 그 결과, 상호 운용이 가능한 통신 규격과 첨단 데이터 분석에 주력하는 제조업체들은 경쟁 우위를 확보하고, 시장에서 수용될 수 있는 기반을 마련해 두었습니다.
자주 묻는 질문
목차
서론
조사 방법
개요
시장 역학과 전망
주요 시장 인사이트
세계의 리드리스 페이스메이커 시장 규모 : 제품 유형별
세계의 리드리스 페이스메이커 시장 규모 : 기술 플랫폼별
세계의 리드리스 페이스메이커 시장 규모 : 최종사용자별
세계의 리드리스 페이스메이커 시장 규모 : 유통 채널별
세계의 리드리스 페이스메이커 시장 규모 : 지역별
경쟁 정보
주요 기업 개요
결론과 제안
KSA 26.07.22Global Leadless Pacemakers Market size was valued at USD 670.0 Million in 2024 and is poised to grow from USD 774.52 Million in 2025 to USD 2469.99 Million by 2033, growing at a CAGR of 15.6% during the forecast period (2026-2033).
The leadless pacemaker market signifies a shift in cardiac rhythm management, providing essential advantages by eliminating transvenous leads, thus lowering infection risks and simplifying procedures. This market has gained traction as medical professionals explore alternatives to traditional systems, particularly for patients with challenging venous access or persistent lead-related issues. Clinicians are increasingly adopting leadless technologies due to their efficacy and reduced hospital stays, with significant developments expanding therapeutic uses and reimbursement options. As the global population ages and arrhythmia disorders rise, minimally invasive therapies become increasingly sought after, driving hospitals to invest in efficient delivery systems. Additionally, AI-driven analytics are enhancing leadless pacemaker adoption by enabling better patient management and personalized care, fostering a favorable environment for this innovative technology's growth.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Leadless Pacemakers market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Leadless Pacemakers Market Segments Analysis
Global leadless pacemakers market is segmented by product type, technology platform, end-user, distribution channel and region. Based on product type, the market is segmented into Single-Chamber Leadless Pacemakers and Dual-Chamber Leadless Pacemakers. Based on technology platform, the market is segmented into Intracardiac Transcatheter Pacing Systems and Subcutaneous Co-axial Systems. Based on end-user, the market is segmented into Hospitals & Cardiac Centers and Ambulatory Surgical Centers. Based on distribution channel, the market is segmented into Direct and Indirect. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Global Leadless Pacemakers Market
One of the key market drivers for the global leadless pacemakers market is the increasing prevalence of cardiovascular diseases, which has heightened the demand for advanced cardiac care solutions. As patients seek less invasive treatment options, leadless pacemakers, which eliminate the need for traditional leads and significantly reduce the risk of complications such as infections and lead-related issues, are gaining popularity among both healthcare providers and patients. Additionally, advancements in medical technology and ongoing research and development efforts are fostering innovation in leadless pacemaker designs, enhancing their efficacy and safety profiles, and further driving their adoption in clinical practice.
Restraints in the Global Leadless Pacemakers Market
One significant market restraint for the global leadless pacemakers market is the high cost of these advanced devices compared to traditional pacemaker systems. The initial investment required for procurement, along with the associated procedural expenses, can be a barrier for many healthcare facilities, particularly in developing regions with limited budgets. Additionally, the lack of awareness and understanding of leadless technology among healthcare professionals and patients may hinder adoption. Challenges related to reimbursement policies and limited insurance coverage for innovative cardiac devices further complicate market penetration, affecting both patient access and overall market growth in various regions.
Market Trends of the Global Leadless Pacemakers Market
The Global Leadless Pacemakers market is experiencing a significant shift towards the integration of remote monitoring systems. This trend emphasizes continuous telemetry, allowing healthcare providers to track device performance and patient rhythm data seamlessly. By reducing in-person visits, these innovations enhance early detection of arrhythmic events and support proactive clinical decision-making. The expansion of telehealth infrastructure globally further fuels this demand, with clinicians favoring solutions that ensure efficient data transmission to centralized platforms, thereby improving patient safety and convenience. As a result, manufacturers focusing on interoperable communication standards and advanced data analytics are poised to gain a competitive edge and foster market acceptance.
Table of Contents
Introduction
- Objectives of the Study
- Market Definition & Scope
Research Methodology
- Research Process
- Secondary & Primary Data Methods
- Market Size Estimation Methods
Executive Summary
- Global Market Outlook
- Key Market Highlights
- Segmental Overview
- Competition Overview
Market Dynamics & Outlook
- Macro-Economic Indicators
- Drivers & Opportunities
- Restraints & Challenges
- Supply Side Trends
- Demand Side Trends
- Porters Analysis & Impact
- Competitive Rivalry
- Threat of Substitute
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
Key Market Insights
- Key Success Factors
- Market Impacting Factors
- Top Investment Pockets
- Ecosystem Mapping
- Market Attractiveness Index 2025
- PESTEL Analysis
- Regulatory Landscape
Global Leadless Pacemakers Market Size by Product Type & CAGR (2026-2033)
- Market Overview
- Single-Chamber Leadless Pacemakers
- Dual-Chamber Leadless Pacemakers
Global Leadless Pacemakers Market Size by Technology Platform & CAGR (2026-2033)
- Market Overview
- Intracardiac Transcatheter Pacing Systems
- Subcutaneous Co-axial Systems
Global Leadless Pacemakers Market Size by End-User & CAGR (2026-2033)
- Market Overview
- Hospitals & Cardiac Centers
- Ambulatory Surgical Centers
Global Leadless Pacemakers Market Size by Distribution Channel & CAGR (2026-2033)
- Market Overview
- Direct
- Indirect
Global Leadless Pacemakers Market Size & CAGR (2026-2033)
- North America (Product Type, Technology Platform, End-User, Distribution Channel)
- US
- Canada
- Europe (Product Type, Technology Platform, End-User, Distribution Channel)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
- Asia Pacific (Product Type, Technology Platform, End-User, Distribution Channel)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Latin America (Product Type, Technology Platform, End-User, Distribution Channel)
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa (Product Type, Technology Platform, End-User, Distribution Channel)
- GCC Countries
- South Africa
- Rest of Middle East & Africa
Competitive Intelligence
- Top 5 Player Comparison
- Market Positioning of Key Players, 2025
- Strategies Adopted by Key Market Players
- Recent Developments in the Market
- Company Market Share Analysis, 2025
- Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)
Key Company Profiles
- Medtronic
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Abbott Laboratories
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Boston Scientific Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Biotronik
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- LivaNova
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- MicroPort Scientific Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Lepu Medical Technology
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Osypka Medical
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Shigeta Medical
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Cardiofocus
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Pacetronix
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- CCC Medical Devices
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Shree Pacetronix
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Oscor Inc
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Integer Holdings Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- EBR Systems
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Cathay Medical
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Vitatron
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Sorin Group
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Cordis
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
